30 Stocks Moving In Tuesday's Mid-Day Session

Gainers

• InspireMD, Inc. (NYSE:NSPR) jumped 28 percent to $2.61 after the company disclosed that it has received regulatory approval for both CGuard EPS and MGuard Prime in Peru.
• Astrotech Corporation (NASDAQ:ASTC) shares climbed 22.3 percent to $2.47 as the company disclosed that its new explosives trace detector, the TRACER 1000, has been accepted into the Transportation Security Administration’s Air Cargo Screening Technology Qualification Test program..
• Sears Hometown and Outlet Stores, Inc. (NASDAQ:SHOS) shares climbed 19.1 percent to $2.50.
• Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) rose 14.1 percent to $7.92 as the company reported that it has begun dosing in Phase 1/2 study of ARO-HBV for the treatment of chronic hepatitis B. Jefferies initiated coverage on Arrowhead Pharma with a Buy rating and a $10.00 price target.
• ShiftPixy, Inc. (NASDAQ:PIXY) gained 12.4 percent to $3.1596. ShiftPixy disclosed that it is utilizing IBM Watson's AI engine across its platform.
• Helios and Matheson Analytics Inc. (NASDAQ:HMNY) jumped 11.8 percent to $3.420.
• Enphase Energy, Inc. (NASDAQ:ENPH) shares surged 11 percent to $5.46.
• Top Ships Inc. (NASDAQ:TOPS) shares rose 10.9 percent to $2.44.
• Nova Lifestyle, Inc. (NASDAQ:NVFY) shares gained 10.3 percent to $2.58. Nova Lifestyle is expected to release 2017 results on March 29.
• Aratana Therapeutics, Inc. (NASDAQ:PETX) climbed 7.5 percent to $4.16. Stifel Nicolaus upgraded Aratana Therapeutics from Hold to Buy.
• Cheetah Mobile Inc. (NYSE:CMCM) rose 7.5 percent to $12.26 after declining 6.32 percent on Monday.
• Sierra Wireless, Inc. (NASDAQ:SWIR) shares gained 6 percent to $16.75. Roth Capital upgraded Sierra Wireless from Neutral to Buy.
• Red Hat, Inc. (NYSE:RHT) rose 4 percent to $159.05 after the company reported better-than-expected results for its fourth quarter. The company also issued strong first-quarter and fiscal 2019 earnings and sales guidance.
• GlaxoSmithKline plc (NYSE:GSK) shares rose 3.2 percent to $38.61 after Novartis agreed to sell stake in consumer healthcare joint venture to GSK for $13 billion.

Check out these big penny stock gainers and losers

Losers

• Longfin Corp. (NASDAQ:LFIN) declined 33.7 percent to $39.3303 after declining 16.62 percent on Monday. FTSE Russell release showed that the co. failed to meet minimum 5% free float requirement as of February 14 cut-off date and will be removed from the Russell Indexes on March 28 after the close.
• RXi Pharmaceuticals Corporation (NASDAQ:RXII) dropped 15.8 percent to $3.42 after the company reported Q4 results and recent corporate highlights. RXi Pharma posted aQ4 loss of $0.84 per share on sales of $15,000.
• InVitae Corp (NYSE:NVTA) dipped 14.6 percent to $5.975 after reporting a $50-million common stock offering.
• Cogint, Inc. (NASDAQ:COGT) fell 14.5 percent to $2.87.
• Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) shares declined 14.1 percent to $1.7775.
• IDT Corporation (NYSE:IDT) shares fell 12.6 percent to $8.63. IDT disclosed that it has completed the spin-off of Rafael Holdings.
• MacroGenics, Inc. (NASDAQ:MGNX) dropped 12 percent to $25.44 after reporting an offering of 4.5 million shares of common stock.
• American Renal Associates Holdings, Inc. (NYSE:ARA) tumbled 11.3 percent to $18.92 after the company reported an offering of 5 million shares by selling holders.
• Geron Corporation (NASDAQ:GERN) shares dropped 10.5 percent to $5.3548 after rising 6.03 percent on Monday.
• Tintri, Inc. (NASDAQ:TNTR) declined 9.3 percent to $2.06.
• Staffing 360 Solutions, Inc. (NASDAQ:STAF) shares fell 9.2 percent to $2.2600.
• Overstock.com, Inc. (NASDAQ:OSTK) slipped 8.8 percent to $40.675 after announcing a proposed 4-million-share common stock offering.
• Unit Corporation (NYSE:UNT) fell 8.4 percent to $17.76. SunTrust Robinson Humphrey downgraded Unit from Buy to Hold.
• Arcadia Biosciences, Inc. (NASDAQ:RKDA) fell 7.7 percent to $24.20 after dipping 13.92 percent on Monday.
• ITUS Corporation (NASDAQ:ITUS) fell 5.8 percent to $4.01. ITUS and Serametrix disclosed results of a blinded prostate cancer study.
• Gladstone Land Corporation (NASDAQ:LAND) shares fell 4.2 percent to $12.17 following announcement of common stock offering.